Isatuximab subcutaneous by on-body injector in Relapsed/Refractory multiple myeloma in the Phase 3 iraklia study: Effect of body weight on pharmacokinetics and clinical outcome
Year: 2025
Type: conference-abstract
Source: Blood
Authors: Jin Lu, Albert Oriol, Alejandro Berkovits, Andrew Spencer, Cesar Gomez, Chunrui Li, Claudio Cerchione, Fei Li, Fredrik Schjesvold, Gurdeep Parmar, Ivan Špička, Marek Hus, Maria del Rosario Custidiano, Meletios Dimopoulos, Peter Rajnics, Sevgi Kalayoglu Besisik, Sikander Ailawadhi, Silvia Ling, Vania Hungria, Xavier Leleu, Florence Suzan Teisserenc, Maya Stefanova-Urena, Rick Zhang, Victorine Koch, Dorothee Semiond
Institutions: Peking University, Institut Català d'Oncologia, Hospital Universitari Germans Trias i Pujol, Monash University, Norfolk and Norwich University Hospital, Norfolk and Norwich University Hospitals NHS Foundation Trust, Huazhong University of Science and Technology, University of Bologna, Harbin Medical University, Charles University, Instituto Alexander Fleming, National and Kapodistrian University of Athens, Somogy Megyei Kaposi Mór Oktató Kórház, Istanbul University, Mayo Clinic in Florida, Sydney Adventist Hospital, Irmandade da Santa Casa de Misericórdia de São Paulo, Centre Hospitalier Universitaire de Poitiers, Sanofi (France)
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4417011603
Cites:
Cited by:
Related to: